ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
1.11
-0.11 (-9.02%)
At close: Sep 08, 2025, 3:59 PM
1.14
2.70%
After-hours: Sep 08, 2025, 06:57 PM EDT
-9.02% (1D)
| Bid | 1.07 |
| Market Cap | 59.44M |
| Revenue (ttm) | 868K |
| Net Income (ttm) | -116.57M |
| EPS (ttm) | -2.16 |
| PE Ratio (ttm) | -0.51 |
| Forward PE | -1.28 |
| Analyst | Buy |
| Ask | 1.17 |
| Volume | 350,583 |
| Avg. Volume (20D) | 939,566 |
| Open | 1.19 |
| Previous Close | 1.22 |
| Day's Range | 1.09 - 1.22 |
| 52-Week Range | 0.40 - 2.36 |
| Beta | 1.12 |
About ALXO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALXO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALXO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-19.08%
ALX Oncology Holdings shares are trading lower. Th...
Unlock content with
Pro Subscription
6 months ago
+25.96%
ALX Oncology Holdings shares are trading higher after Piper Sandler and Jefferies upgraded their respective price targets on the stock.
4 weeks ago · seekingalpha.com
ALX Oncology Holdings Inc. (ALXO) Q2 2025 Earnings Call TranscriptALX Oncology Holdings Inc. (NASDAQ:ALXO ) Q2 2025 Earnings Conference Call August 12, 2023 4:30 AM ET Company Participants Alan Bart Sandler - Chief Medical Officer Harish Shantharam - Chief Financial...